AB
Amalgamated Bank Portfolio holdings
AUM
$13B
1-Year Return
23.92%
This Quarter Return
+8.23%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$12.5B
AUM Growth
+$9.81B
(+368%)
Cap. Flow
+$9.6B
Cap. Flow
% of AUM
76.96%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
2,209
New
604
Increased
1,565
Reduced
9
Closed
28
Top Buys
| 1 |
Apple
AAPL
|
$368M |
| 2 |
Microsoft
MSFT
|
$351M |
| 3 |
Amazon
AMZN
|
$255M |
| 4 |
Meta Platforms (Facebook)
META
|
$143M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$132M |
Top Sells
| 1 |
HubSpot
HUBS
|
$1.89M |
| 2 |
iShares Russell 3000 ETF
IWV
|
$1.7M |
| 3 |
Zscaler
ZS
|
$1.62M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
$1.59M |
| 5 |
RP
RealPage, Inc.
RP
|
$1.36M |
Sector Composition
| 1 | Technology | 21.3% |
| 2 | Financials | 14.4% |
| 3 | Healthcare | 12.88% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSP
2101
BrightSpire Capital
BRSP
$776M
| $117K | ﹤0.01% |
+12,395
| New | +$117K |
|
|
PAE
2102
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $117K | ﹤0.01% |
+13,112
| New | +$117K |
|
2103
Advantage Solutions
ADV
$580M
| $116K | ﹤0.01% |
+10,730
| New | +$116K |
|
|
ASXC
2104
DELISTED
Asensus Surgical, Inc.
ASXC
| $115K | ﹤0.01% |
+36,400
| New | +$115K |
|
2105
Ardelyx
ARDX
$1.58B
| $114K | ﹤0.01% |
14,996
+4,484
| +43% | +$34.1K |
|
|
VBIV
2106
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $114K | ﹤0.01% |
1,137
+290
| +34% | +$29.1K |
|
2107
Acco Brands
ACCO
$365M
| $113K | ﹤0.01% |
+13,092
| New | +$113K |
|
2108
Precigen
PGEN
$1.36B
| $113K | ﹤0.01% |
+17,328
| New | +$113K |
|
2109
SFL Corp
SFL
$1.09B
| $112K | ﹤0.01% |
+14,684
| New | +$112K |
|
|
MGI
2110
DELISTED
MoneyGram International, Inc. New
MGI
| $110K | ﹤0.01% |
+10,951
| New | +$110K |
|
2111
VistaGen Therapeutics
VTGN
$113M
| $109K | ﹤0.01% |
+1,154
| New | +$109K |
|
|
CLVS
2112
DELISTED
Clovis Oncology, Inc.
CLVS
| $109K | ﹤0.01% |
18,811
+7,009
| +59% | +$40.6K |
|
2113
Uranium Energy
UEC
$4.9B
| $107K | ﹤0.01% |
40,082
+19,966
| +99% | +$53.3K |
|
2114
Atossa Therapeutics
ATOS
$101M
| $106K | ﹤0.01% |
+16,827
| New | +$106K |
|
2115
MRC Global
MRC
$1.28B
| $106K | ﹤0.01% |
+11,308
| New | +$106K |
|
2116
Alaunos Therapeutics
TCRT
$4.15M
| $105K | ﹤0.01% |
264
+76
| +40% | +$30.2K |
|
|
CMRX
2117
DELISTED
Chimerix, Inc.
CMRX
| $102K | ﹤0.01% |
+12,792
| New | +$102K |
|
|
VIEW
2118
DELISTED
View, Inc. Class A Common Stock
VIEW
| $101K | ﹤0.01% |
+198
| New | +$101K |
|
|
SNR
2119
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $101K | ﹤0.01% |
+11,507
| New | +$101K |
|
2120
Akebia Therapeutics
AKBA
$782M
| $98K | ﹤0.01% |
25,765
+3,381
| +15% | +$12.9K |
|
2121
Team
TISI
$86.5M
| $98K | ﹤0.01% |
+1,464
| New | +$98K |
|
2122
Amneal Pharmaceuticals
AMRX
$3B
| $96K | ﹤0.01% |
18,831
+4,821
| +34% | +$24.6K |
|
2123
TETRA Technologies
TTI
$625M
| $95K | ﹤0.01% |
+21,819
| New | +$95K |
|
2124
Veru
VERU
$48.3M
| $89K | ﹤0.01% |
+1,107
| New | +$89K |
|
2125
PAVmed
PAVM
$9.8M
| $87K | ﹤0.01% |
+905
| New | +$87K |
|